Alphamab Oncology (HKG:9966)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.70
-0.04 (-0.52%)
At close: Mar 27, 2026

Alphamab Oncology Statistics

Total Valuation

HKG:9966 has a market cap or net worth of HKD 7.46 billion. The enterprise value is 6.09 billion.

Market Cap7.46B
Enterprise Value 6.09B

Important Dates

The last earnings date was Wednesday, March 25, 2026.

Earnings Date Mar 25, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:9966 has 968.57 million shares outstanding. The number of shares has decreased by -3.52% in one year.

Current Share Class 968.57M
Shares Outstanding 968.57M
Shares Change (YoY) -3.52%
Shares Change (QoQ) -2.06%
Owned by Insiders (%) 50.12%
Owned by Institutions (%) 3.22%
Float 483.14M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 11.84
PB Ratio 3.92
P/TBV Ratio 3.92
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -48.05
EV / Sales 9.67
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.67, with a Debt / Equity ratio of 0.07.

Current Ratio 5.67
Quick Ratio 5.29
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -20.58

Financial Efficiency

Return on equity (ROE) is -6.43% and return on invested capital (ROIC) is -4.97%.

Return on Equity (ROE) -6.43%
Return on Assets (ROA) -4.42%
Return on Invested Capital (ROIC) -4.97%
Return on Capital Employed (ROCE) -8.44%
Weighted Average Cost of Capital (WACC) 6.40%
Revenue Per Employee 1.30M
Profits Per Employee -261,968
Employee Count484
Asset Turnover 0.26
Inventory Turnover 0.67

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +8.57% in the last 52 weeks. The beta is 0.40, so HKG:9966's price volatility has been lower than the market average.

Beta (5Y) 0.40
52-Week Price Change +8.57%
50-Day Moving Average 8.83
200-Day Moving Average 9.78
Relative Strength Index (RSI) 37.62
Average Volume (20 Days) 1,226,885

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:9966 had revenue of HKD 630.11 million and -126.79 million in losses. Loss per share was -0.13.

Revenue630.11M
Gross Profit 559.40M
Operating Income -170.58M
Pretax Income -126.79M
Net Income -126.79M
EBITDA -98.98M
EBIT -170.58M
Loss Per Share -0.13
Full Income Statement

Balance Sheet

The company has 1.50 billion in cash and 136.85 million in debt, with a net cash position of 1.37 billion or 1.41 per share.

Cash & Cash Equivalents 1.50B
Total Debt 136.85M
Net Cash 1.37B
Net Cash Per Share 1.41
Equity (Book Value) 1.90B
Book Value Per Share 2.03
Working Capital 1.46B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 72.93M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 88.78%, with operating and profit margins of -27.07% and -20.12%.

Gross Margin 88.78%
Operating Margin -27.07%
Pretax Margin -20.12%
Profit Margin -20.12%
EBITDA Margin -15.71%
EBIT Margin -27.07%
FCF Margin n/a

Dividends & Yields

HKG:9966 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 3.52%
Shareholder Yield 3.52%
Earnings Yield -1.70%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2